Waters Honors School of Pharmacy at University of Maryland Institution First to Be Recognized by Waters Centers of Innovation Program for Mass Spectrometry Research and Education
MILFORD, Mass., Nov. 12, 2013 /PRNewswire/ -- Discovery and education were the main themes at a recent ceremony and symposium at the University of Maryland School of Pharmacy (UMSOP), an institution which Waters Corporation honored for its interdisciplinary research using mass spectrometry to discover new and improved drugs to treat cancer, diabetes and infectious diseases. During an on-campus ceremony, Waters Corporation officially recognized the UMSOP Department of Pharmaceutical Sciences' core Mass Spectrometry Facility under the direction of David Goodlett, PhD, the Isaac E. Emerson Chair of Pharmaceutical Sciences, as the first such institution to be selected for Waters Centers of Innovation Program honors.
As part of the Waters Centers of Innovation Program, the School of Pharmacy will continue to receive priority access to new technologies, opportunities to influence the development of next-generation research instruments, shared opportunities for collaboration with Waters and priority applications support and funding assistance.
University of Maryland, Baltimore President Jay A. Perman, MD, addressed the audience saying, "Today's ceremony is a testament to the achievements of this School. Our new Mass Spectrometry Facility is the largest, most-well equipped and well-staffed facility of its kind in the Mid-Atlantic region and it will enable us to shorten the time it takes to translate research findings into new diagnostics, therapeutics, and preventive procedures that will help patients."
Representing Waters Corporation, Mark Groudas, V.P., Americas Field Operations, said, "With the selection of the University of Maryland School of Pharmacy for the Waters Centers of Innovation Program, Waters officially acknowledges the contributions of the School of Pharmacy and the long-standing relationship we have had with one another. By continuing to work with one another and invest in each other's success, we can accomplish great things."
In association with the recognition ceremony, the School of Pharmacy and Waters co-organized a day-long scientific symposium titled "Empowering Biomarker Discovery and Therapeutic Solutions via Mass Spectrometry." The Symposium opened with a lecture from Goodlett, who is also director of the Mass Spectrometry Facility at the School of Pharmacy, followed by Maureen Kane, PhD, assistant professor of pharmaceutical sciences and co-director of the Mass Spectrometry Facility. The Symposium featured other researchers in the field including Arthur Moseley, PhD, associate research professor at Duke University and director of Duke's Proteomics Core Facility; Joseph Loo, PhD, a professor of chemistry and biochemistry from the University of California, Los Angeles; Patrick Wintrode, PhD, associate professor of pharmaceutical sciences at the School of Pharmacy; and Ron Heeren, PhD, professor of the FOM Institute AMOLF in Amsterdam.
Mass Spectrometry at the University of Maryland
The School of Pharmacy's Mass Spectrometry Facility came together largely due to the vision of Dean Natalie D. Eddington, PhD, FAAPS, FCP.
"Without access to an adequate mass spec facility, faculty from many of the schools at the University have had to use other facilities in the Baltimore area and those located in other cities, making it difficult, if not impossible, to leverage interdisciplinary teams and training opportunities for our faculty, students and fellows," Eddington told the audience. "Our vision for the mass spec facility is to offer researchers from the School of Pharmacy and the surrounding research community the opportunity to perform a wide range of sophisticated experiments. Our hope is that this first-of-its-kind partnership with Waters will foster the development of new techniques to further the capabilities of mass spectrometry and help solve biomedical problems."
UMSOP's Mass Spectrometry Facility is now home to a total of 15 mass spectrometers and all of which are available to researchers in the fields of proteomics, structural biology, and all facets of drug discovery, design, and development.
About the University of Maryland School of Pharmacy
The University of Maryland School of Pharmacy, the fourth oldest school of pharmacy in the United States, leads pharmacy education, scientific discovery, patient care, and community engagement in the state of Maryland and beyond. With an enrollment of nearly 700 doctor of pharmacy and graduate students, the highly ranked school conducts cutting edge research in drug delivery mechanisms, cost impact studies, basic drug discovery and development, and disease management, and engages in a wide variety of professional practice activities, partnering with over 200 community pharmacies, hospitals, assisted living facilities, and other agencies to provide services to citizens and practitioners around the State and across the nation.
About Waters Centers of Innovation Program
Waters Centers of Innovation Program recognizes and supports the efforts of scientists facilitating breakthroughs in health and life science research, food safety, environmental protection, sports medicine and many other areas.
The researchers and research centers previously selected for the Waters Centers of Innovation Program includes: Professor Ganesh Anand, National University of Singapore; Professor David Clemmer, Indiana University, Bloomington, Indiana; Professor David Cowan, Kings College London; Dr. Joseph Dalluge, University of Minnesota; Professor Marcos Eberlin, University of Campinas, Brazil; Prof. Chris Elliott, Queen's University Belfast, Northern Ireland; Professor John Engen, Northeastern University, Boston, Mass.; Professor Albert J. Fornace, Jr., Georgetown Lombardi Comprehensive Cancer Center, Washington, D.C.; Dr. Frank Gonzalez, National Cancer Institute; Professor Julie Leary of the University of California – Davis; Professor Amit Kumar Mandal, St. John's Research Institute, Bangalore, India; Professor Arthur Moseley of Duke University, Durham, North Carolina; Professor Jeremy Nicholson, Imperial College London; Dr. Devin Peterson, University of Minnesota; Dr. Konstantinos Petritis, Translational Genomics Research Institute, Phoenix, Arizona; Dr. Ryan Rogers, Future Fuels Institute, Florida State University; Professor Pauline Rudd, National Institute for Bioprocessing Research and Training; Professor Vladimir Shulaev, University of North Texas; Professor James Scrivens, University of Warwick, Coventry, UK; Professor Sarah Trimpin, Wayne State University; Professor Bert van Bavel, Orebro University, Orebro, Sweden and Caroline West and Eric Lesselier, University of Orleans, Orleans, France.
About Waters Corporation (www.waters.com)
For over 50 years, Waters Corporation (NYSE: WAT) has created business advantages for laboratory-dependent organizations by delivering practical and sustainable innovation to enable significant advancements in such areas as healthcare delivery, environmental management, food safety, and water quality worldwide.
Pioneering a connected portfolio of separations science, laboratory information management, mass spectrometry and thermal analysis, Waters technology breakthroughs and laboratory solutions provide an enduring platform for customer success.
With revenue of $1.84 billion in 2012, Waters is driving scientific discovery and operational excellence for customers worldwide.
Waters is a trademark of Waters Corporation.
SOURCE Waters Corporation